| pubmed-article:11231346 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11231346 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11231346 | lifeskim:mentions | umls-concept:C0024264 | lld:lifeskim |
| pubmed-article:11231346 | lifeskim:mentions | umls-concept:C0019143 | lld:lifeskim |
| pubmed-article:11231346 | lifeskim:mentions | umls-concept:C0022663 | lld:lifeskim |
| pubmed-article:11231346 | lifeskim:mentions | umls-concept:C1704321 | lld:lifeskim |
| pubmed-article:11231346 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:11231346 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:11231346 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11231346 | pubmed:dateCreated | 2001-3-20 | lld:pubmed |
| pubmed-article:11231346 | pubmed:abstractText | Lymphocytes are involved in the physiopathologic mechanism of idiopathic nephrotic syndrome (INS). We have recently demonstrated that plasma from patients with INS decreases human glomerular epithelial cell (GEC) glycosaminoglycans (GAGs), particularly heparan sulfates (HS) in vitro. In this study we investigate the effect of peripheral blood lymphocytes (PBL) from INS patients on glomerular cell GAG and HS. | lld:pubmed |
| pubmed-article:11231346 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11231346 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11231346 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11231346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11231346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11231346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11231346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11231346 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11231346 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11231346 | pubmed:issn | 0085-2538 | lld:pubmed |
| pubmed-article:11231346 | pubmed:author | pubmed-author:ThibaultGG | lld:pubmed |
| pubmed-article:11231346 | pubmed:author | pubmed-author:NivetHH | lld:pubmed |
| pubmed-article:11231346 | pubmed:author | pubmed-author:GirardinE PEP | lld:pubmed |
| pubmed-article:11231346 | pubmed:author | pubmed-author:BirmeleBB | lld:pubmed |
| pubmed-article:11231346 | pubmed:author | pubmed-author:de AgostiniAA | lld:pubmed |
| pubmed-article:11231346 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11231346 | pubmed:volume | 59 | lld:pubmed |
| pubmed-article:11231346 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11231346 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11231346 | pubmed:pagination | 913-22 | lld:pubmed |
| pubmed-article:11231346 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:meshHeading | pubmed-meshheading:11231346... | lld:pubmed |
| pubmed-article:11231346 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11231346 | pubmed:articleTitle | In vitro decrease of glomerular heparan sulfate by lymphocytes from idiopathic nephrotic syndrome patients. | lld:pubmed |
| pubmed-article:11231346 | pubmed:affiliation | Department of Pediatrics, University Hospital of Geneva, Geneva, Switzerland. | lld:pubmed |
| pubmed-article:11231346 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11231346 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
